Retour
Prix Epigenomics AG (EPGNF)
Graphique du cours de l'action EPGNF
EPGNF Gagner
Epigenomics AG
$1.12
0%
$0
À la fermeture : Jan 16, 16:00:00 GMT-5
$1.12
0%
$0
Post-Marché: Jan 16, 20:00:00 GMT-5
Statistiques clés
Clôture préc.
$1.12
Prix d'ouverture
$1.12
Plage de la journée
$1.12 - $1.12
Plage de 52 semaines
$0.79 - $1.12
Volume
380
Volume moyen
0
BPA (TTM)
-3.69
Rendement en dividend
--
Capitalisation boursière
$982.1K
Qu’est-ce que EPGNF ?
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. The company is headquartered in Heidelberg, Baden-Wuerttemberg and currently employs 3 full-time employees. The company went IPO on 2004-07-19. The company develops and commercializes blood-based diagnostic products across multiple cancer indications. The firm's main product is Epi proColon, a blood test for colorectal cancer screening. Along with the blood-based tests the Company offers services related to research, product development, regulatory approval and manufacturing of in-vitro diagnostic (IVD) products. The company also offers Epi proLung, a blood-based test that detects the presence of lung cancer in blood plasma. The firm is present in Europe and the United States.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved